S&P 500   3,861.30 (+0.50%)
DOW   32,046.62 (+1.75%)
QQQ   303.72 (-1.61%)
AAPL   117.43 (-3.29%)
MSFT   229.83 (-0.76%)
FB   258.80 (-2.07%)
GOOGL   2,044.88 (-2.49%)
TSLA   576.54 (-3.58%)
AMZN   3,004.60 (+0.14%)
NVDA   470.80 (-5.55%)
BABA   228.60 (-2.26%)
CGC   31.44 (+0.87%)
GE   14.23 (+4.63%)
MU   86.37 (-2.88%)
NIO   36.13 (-5.20%)
AMD   75.44 (-3.92%)
T   30.37 (+2.53%)
F   12.64 (+3.02%)
ACB   9.71 (+1.15%)
DIS   200.16 (+5.35%)
BA   226.64 (+1.53%)
NFLX   503.98 (-2.40%)
PFE   34.70 (+0.90%)
S&P 500   3,861.30 (+0.50%)
DOW   32,046.62 (+1.75%)
QQQ   303.72 (-1.61%)
AAPL   117.43 (-3.29%)
MSFT   229.83 (-0.76%)
FB   258.80 (-2.07%)
GOOGL   2,044.88 (-2.49%)
TSLA   576.54 (-3.58%)
AMZN   3,004.60 (+0.14%)
NVDA   470.80 (-5.55%)
BABA   228.60 (-2.26%)
CGC   31.44 (+0.87%)
GE   14.23 (+4.63%)
MU   86.37 (-2.88%)
NIO   36.13 (-5.20%)
AMD   75.44 (-3.92%)
T   30.37 (+2.53%)
F   12.64 (+3.02%)
ACB   9.71 (+1.15%)
DIS   200.16 (+5.35%)
BA   226.64 (+1.53%)
NFLX   503.98 (-2.40%)
PFE   34.70 (+0.90%)
S&P 500   3,861.30 (+0.50%)
DOW   32,046.62 (+1.75%)
QQQ   303.72 (-1.61%)
AAPL   117.43 (-3.29%)
MSFT   229.83 (-0.76%)
FB   258.80 (-2.07%)
GOOGL   2,044.88 (-2.49%)
TSLA   576.54 (-3.58%)
AMZN   3,004.60 (+0.14%)
NVDA   470.80 (-5.55%)
BABA   228.60 (-2.26%)
CGC   31.44 (+0.87%)
GE   14.23 (+4.63%)
MU   86.37 (-2.88%)
NIO   36.13 (-5.20%)
AMD   75.44 (-3.92%)
T   30.37 (+2.53%)
F   12.64 (+3.02%)
ACB   9.71 (+1.15%)
DIS   200.16 (+5.35%)
BA   226.64 (+1.53%)
NFLX   503.98 (-2.40%)
PFE   34.70 (+0.90%)
S&P 500   3,861.30 (+0.50%)
DOW   32,046.62 (+1.75%)
QQQ   303.72 (-1.61%)
AAPL   117.43 (-3.29%)
MSFT   229.83 (-0.76%)
FB   258.80 (-2.07%)
GOOGL   2,044.88 (-2.49%)
TSLA   576.54 (-3.58%)
AMZN   3,004.60 (+0.14%)
NVDA   470.80 (-5.55%)
BABA   228.60 (-2.26%)
CGC   31.44 (+0.87%)
GE   14.23 (+4.63%)
MU   86.37 (-2.88%)
NIO   36.13 (-5.20%)
AMD   75.44 (-3.92%)
T   30.37 (+2.53%)
F   12.64 (+3.02%)
ACB   9.71 (+1.15%)
DIS   200.16 (+5.35%)
BA   226.64 (+1.53%)
NFLX   503.98 (-2.40%)
PFE   34.70 (+0.90%)
Log in
NASDAQ:CLOV

Clover Health Investments Stock Forecast, Price & News

$7.51
-0.33 (-4.21 %)
(As of 03/8/2021 02:14 PM ET)
Add
Compare
Today's Range
$7.42
Now: $7.51
$8.11
50-Day Range
$7.29
MA: $12.21
$15.76
52-Week Range
$6.31
Now: $7.51
$17.45
Volume269,938 shs
Average Volume19.25 million shs
Market Capitalization$777.29 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Clover Health Investments, Corp. operates as a Medicare Advantage insurer in the United States. The company through its software platform provides preferred provider organization and health maintenance organization health plans for Medicare-eligible consumers. Clover Health Investments, Corp. was founded in 2012 and is headquartered in Franklin, Tennessee.

Headlines

Is Clover Health Stock a Buy?
March 6, 2021 |  nasdaq.com
See More Headlines

Industry, Sector and Symbol

Industry Hospital & medical service plans
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:CLOV
CUSIPN/A
CIKN/A
Phone650-521-9007
Employees327
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$777.29 million
Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

1.48 out of 5 stars

Medical Sector

516th out of 1,968 stocks

Hospital & Medical Service Plans Industry

8th out of 11 stocks

Analyst Opinion: 3.3Community Rank: 3.3Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -
$7.51
-0.33 (-4.21 %)
(As of 03/8/2021 02:14 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CLOV News and Ratings via Email

Sign-up to receive the latest news and ratings for CLOV and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Clover Health Investments (NASDAQ:CLOV) Frequently Asked Questions

Is Clover Health Investments a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Clover Health Investments in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Clover Health Investments stock.
View analyst ratings for Clover Health Investments
or view top-rated stocks.

What stocks does MarketBeat like better than Clover Health Investments?

Wall Street analysts have given Clover Health Investments a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Clover Health Investments wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Clover Health Investments?

Clover Health Investments saw a increase in short interest in February. As of February 12th, there was short interest totaling 19,850,000 shares, an increase of 55.6% from the January 28th total of 12,760,000 shares. Based on an average daily trading volume, of 14,570,000 shares, the days-to-cover ratio is presently 1.4 days. Currently, 6.5% of the company's shares are short sold.
View Clover Health Investments' Short Interest
.

What guidance has Clover Health Investments issued on next quarter's earnings?

Clover Health Investments issued an update on its FY 2021 After-Hours earnings guidance on Monday, March, 1st. The company provided earnings per share (EPS) guidance of -0.52--0.42 for the period. The company issued revenue guidance of $820-850 million.

What price target have analysts set for CLOV?

2 equities research analysts have issued 1 year target prices for Clover Health Investments' shares. Their forecasts range from $13.00 to $15.00. On average, they expect Clover Health Investments' stock price to reach $14.00 in the next twelve months. This suggests a possible upside of 83.2% from the stock's current price.
View analysts' price targets for Clover Health Investments
or view top-rated stocks among Wall Street analysts.

Who are Clover Health Investments' key executives?

Clover Health Investments' management team includes the following people:
  • Mr. Vivek Garipalli, Co-Founder, CEO & Chairman of Directors (Age 42)
  • Mr. Andrew Toy, Co-Founder, Pres, CTO & Director (Age 42, Pay $427.19k)
  • Ms. Gia Lee Esq., Gen. Counsel & Sec. (Age 51, Pay $425.96k)
  • Mr. Joseph Wagner, Chief Financial Officer (Age 47)
  • Ms. Jamie L. Reynoso, Chief Operating Officer (Age 51)
  • Dr. Kumar Dharmarajan, Chief Scientific Officer (Age 41)
  • Ms. Wendy Richey, Chief Compliance Officer
  • Ms. Rachel Fish, Chief People Officer
  • Dr. Sophia Chang M.D., M.P.H., Chief Clinical Informatics Officer (Age 60)
  • Dr. Mark Spektor D.O., M.B.A., Chief Medical Officer (Age 50)

Who are some of Clover Health Investments' key competitors?

What is Clover Health Investments' stock symbol?

Clover Health Investments trades on the NASDAQ under the ticker symbol "CLOV."

Who are Clover Health Investments' major shareholders?

Clover Health Investments' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Advisory Services Network LLC (0.01%) and Valeo Financial Advisors LLC (0.01%).

Which major investors are buying Clover Health Investments stock?

CLOV stock was purchased by a variety of institutional investors in the last quarter, including Advisory Services Network LLC, and Valeo Financial Advisors LLC.

How do I buy shares of Clover Health Investments?

Shares of CLOV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Clover Health Investments' stock price today?

One share of CLOV stock can currently be purchased for approximately $7.64.

How much money does Clover Health Investments make?

Clover Health Investments has a market capitalization of $790.74 million.

How many employees does Clover Health Investments have?

Clover Health Investments employs 327 workers across the globe.

What is Clover Health Investments' official website?

The official website for Clover Health Investments is www.cloverhealth.com.

Where are Clover Health Investments' headquarters?

Clover Health Investments is headquartered at 317 University Ave Suite 200, Palo Alto CA, 94301.

How can I contact Clover Health Investments?

Clover Health Investments' mailing address is 317 University Ave Suite 200, Palo Alto CA, 94301. The company can be reached via phone at 650-521-9007.


This page was last updated on 3/8/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.